HSD3B1 | Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 | Enzymes FDA approved drug targets Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
TAC3 | Tachykinin 3 | Disease related genes Predicted secreted proteins
| | | | | Tissue enriched |
ADAM12 | ADAM metallopeptidase domain 12 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
CHAT | Choline O-acetyltransferase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
PRG2 | Proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein) | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PSG7 | Pregnancy specific beta-1-glycoprotein 7 (gene/pseudogene) | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
FOXI3 | Forkhead box I3 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
HGF | Hepatocyte growth factor (hepapoietin A; scatter factor) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
LIN28B | Lin-28 homolog B (C. elegans) | Predicted intracellular proteins
| | | | | Tissue enriched |
PAPPA2 | Pappalysin 2 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
FBN2 | Fibrillin 2 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
IGF2 | Insulin-like growth factor 2 | Cancer-related genes Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
GPR32 | G protein-coupled receptor 32 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
MAGEA8 | Melanoma antigen family A, 8 | Predicted intracellular proteins
| | | | | Tissue enriched |
SLC13A4 | Solute carrier family 13 (sodium/sulfate symporter), member 4 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
VGLL1 | Vestigial-like family member 1 | Predicted intracellular proteins
| | | | | Tissue enriched |
IL1RL1 | Interleukin 1 receptor-like 1 | Candidate cardiovascular disease genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
MSMP | Microseminoprotein, prostate associated | Predicted intracellular proteins
| | | | | Tissue enriched |
EBI3 | Epstein-Barr virus induced 3 | Predicted secreted proteins
| | | | | Tissue enriched |
ANKRD33 | Ankyrin repeat domain 33 | Predicted intracellular proteins
| | | | | Tissue enriched |
FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
FLT1 | Fms-related tyrosine kinase 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
PAGE4 | P antigen family, member 4 (prostate associated) | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enriched |
GNGT1 | Guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enriched |
MEST | Mesoderm specific transcript | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
CRH | Corticotropin releasing hormone | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
EPYC | Epiphycan | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
FOXO4 | Forkhead box O4 | Cancer-related genes Disease related genes Predicted intracellular proteins RAS pathway related proteins Transcription factors
| | | | | Tissue enriched |
PHLDA2 | Pleckstrin homology-like domain, family A, member 2 | Predicted intracellular proteins
| | | | | Tissue enriched |
TRIM64B | Tripartite motif containing 64B | Predicted intracellular proteins
| | | | | Tissue enriched |
WNT3A | Wingless-type MMTV integration site family, member 3A | Predicted secreted proteins
| | | | | Tissue enriched |
ACKR2 | Atypical chemokine receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
SERPINE2 | Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |